Evidence map›Paper›PMID 41889705›Full record

ArticleRisk management and healthcare policy2026

Feasibility Study on Risk Stratification for Multidrug-Resistant Organism Infections Among ICU Patients in the United Arab Emirates.

Jumana Mohamed Fouad Al-Salloum, Sabariah Noor Harun, Subish Palaian

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jumana Mohamed Fouad Al-Salloum *Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town, Pulau Penang, Malaysia.
Sabariah Noor Harun *Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town, Pulau Penang, Malaysia.ORCID 0000-0001-8476-7425
Subish Palaian *Department of Clinical Sciences, Ajman University, Ajman, United Arab Emirates.ORCID 0000-0002-9323-3940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Global MDRO risk prediction tools are less applicable in UAE due to the variety in health profiles across all health sectors. Tools built using risk factors based on demographic structure of the country are more clinically applicable. This pilot retrospective case-control study aimed to identify potential risk factors associated with MDRO infections among critically ill patients in a UAE tertiary hospital and to assess the feasibility of conducting a larger-scale study for the future development of an empirical antibiotic selection tool. Patients and Methods: Data were collected from a tertiary care academic hospital in Sharjah. Patients admitted to the ICU for more than 24 hours for a hospital-acquired infection between March to May 2022 were included. A total of 39 patients profiles were screened through random sampling. Potential risk factors for MDRO infections were identified. Student's Results: Collected patient profiles were divided into three groups: MDRO (n = 11), Non-MDRO (n = 10), and no-growth (n = 18). Preliminary risk factors, such as history of bacterial growth was identified to put patients at 2.83 folds of risk of getting MDRO infection ( Conclusion: This study provides preliminary insights into potential risk factors for MDRO infections in ICU of UAE population, such as the need for tube feeding and tracheostomy. The study successfully demonstrated the feasibility of data collection and stratification of patients. The observed trends support the need for a larger, adequately powered study to validate these risk factors and to facilitate the development of a predictive risk assessment tool.

Indexed as

antibiotic stewardshipantimicrobial resistancecritical careepidemiological factorsrisk assessment toolUAE

Identifiers

PMID41889705
PMCPMC13016107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.